Balance Sheet The Trendlines Group Ltd.

Equities

42T

IL0011328858

Investment Management & Fund Operators

Market Closed - Singapore S.E. Other stock markets 10:51:27 2024-09-05 pm EDT			5-day change	1st Jan Change
0.0560 ^SGD	-1.75%		+1.82%	-38.46%

Aug. 28	Trendlines Secures $1.5 Million Investment from Controlling Shareholder	MT
Aug. 27	Vensica Medical Ltd. announced that it expects to receive $0.128 million in funding from Librae Holdings Limited, The Trendlines Group Ltd.	CI

23b145a5.h4HscsxUbtZL3FOhAdnqstLHJ864ECZbGRDQ3FF50MQ.77epC_0QCu94rQPHLL_cn4aMf_7bSFZufkCa7TA2h6zF04dLvmMm536UZw

Published financial data: THE TRENDLINES GROUP LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	5.5M	3.84M	2.3M	3.58M	4.5M
Gain (Loss) on Sale of Investment, Total (Rev)	3.75M	-11M	9.15M	-2.47M	-27.03M
Interest And Invest. Income (Rev)	64K	129K	22K	35K	183K
Other Revenues, Total	313K	4.17M	4.65M	1.23M	1.36M
Total Revenues	9.63M	-2.85M	16.12M	2.37M	-20.99M
Cost of Goods Sold, Total	8.18M	9.02M	12.64M	11.62M	9.83M
Gross Profit	1.45M	-11.87M	3.49M	-9.24M	-30.81M
Selling General & Admin Expenses, Total	269K	214K	328K	270K	241K
R&D Expenses	-	-	-	1.61M	1.69M
Other Operating Expenses, Total	269K	214K	328K	1.88M	1.93M
Operating Income	1.18M	-12.09M	3.16M	-11.12M	-32.74M
Interest Expense, Total	-317K	-179K	-206K	-40K	-
Net Interest Expenses	-317K	-179K	-206K	-40K	-
Currency Exchange Gains (Loss)	-736K	-681K	-155K	-303K	-791K
Other Non Operating Income (Expenses)	5K	-	-153K	-	-284K
EBT, Excl. Unusual Items	137K	-12.95M	2.64M	-11.46M	-33.82M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Other Unusual Items	-	-	-	-5.86M	-905K
EBT, Incl. Unusual Items	137K	-12.95M	2.64M	-17.32M	-34.72M
Income Tax Expense	832K	-9M	-3.36M	-2.16M	-
Earnings From Continuing Operations	-695K	-3.95M	6M	-15.16M	-34.72M
Net Income to Company	-695K	-3.95M	6M	-15.16M	-34.72M
Minority Interest	221K	217K	563K	683K	726K
Net Income - (IS)	-474K	-3.73M	6.56M	-14.48M	-34M
Net Income to Common Incl Extra Items	-474K	-3.73M	6.56M	-14.48M	-34M
Net Income to Common Excl. Extra Items	-474K	-3.73M	6.56M	-14.48M	-34M
Per Share Items
Net EPS - Basic	-0	-0	0.01	-0.02	-0.04
Basic EPS - Continuing Operations	-0	-0	0.01	-0.02	-0.04
Basic Weighted Average Shares Outstanding	655M	791M	791M	840M	922M
Net EPS - Diluted	-0	-0	0.01	-0.02	-0.04
Diluted EPS - Continuing Operations	-0	-0	0.01	-0.02	-0.04
Diluted Weighted Average Shares Outstanding	655M	791M	791M	840M	922M
Normalized Basic EPS	0	-0.01	0	-0.01	-0.02
Normalized Diluted EPS	0	-0.01	0	-0.01	-0.02
American Depositary Receipts Ratio (ADR)	50	50	50	50	50
Supplemental Items
EBITDA	1.49M	-11.34M	3.49M	-10.79M	-32.52M
EBITA	1.18M	-12.09M	3.16M	-11.12M	-32.74M
EBIT	1.18M	-12.09M	3.16M	-11.12M	-32.74M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	9.82M	-2.85M	16.12M	2.37M	-20.93M
Effective Tax Rate - (Ratio)	607.3	69.48	-126.84	12.45	-
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	832K	-9M	-3.36M	-2.16M	-
Normalized Net Income	307K	-7.87M	2.22M	-6.48M	-20.41M
Interest on Long-Term Debt	317K	179K	82K	42K	81K
Supplemental Operating Expense Items
Marketing Expenses	269K	214K	328K	270K	241K
Selling and Marketing Expenses	269K	214K	328K	270K	241K
Research And Development Expense From Footnotes	1.11M	1.09M	1.51M	1.61M	1.69M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	-	80K	-	-	-
Stock-Based Comp., COGS (Total)	103K	299K	252K	677K	316K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-119K	42K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	103K	299K	252K	558K	358K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	18.37M	10.66M	14.31M	5.95M	6.11M
Short Term Investments	200K	-	4.15M	2M	-
Total Cash And Short Term Investments	18.57M	10.66M	18.46M	7.95M	6.11M
Accounts Receivable, Total	422K	187K	667K	2.87M	392K
Other Receivables	302K	2.51M	2.69M	2.08M	2M
Notes Receivable	160K	19K	287K	91K	119K
Total Receivables	884K	2.72M	3.65M	5.03M	2.51M
Other Current Assets, Total	93K	101K	103K	92K	90K
Total Current Assets	19.54M	13.47M	22.21M	13.08M	8.71M
Gross Property Plant And Equipment	5.16M	5.9M	7.84M	7.59M	7.71M
Accumulated Depreciation	-2.05M	-2.82M	-3.88M	-4.69M	-4.78M
Net Property Plant And Equipment	3.11M	3.08M	3.95M	2.91M	2.93M
Long-term Investments	103M	87.86M	83.05M	89.78M	66.41M
Deferred Tax Assets Long-Term	-	6.84M	-	-	-
Other Long-Term Assets, Total	-	5.59M	11.88M	2.23M	28K
Total Assets	125M	117M	121M	108M	78.07M
Liabilities
Accounts Payable, Total	68K	48K	350K	49K	182K
Accrued Expenses, Total	1.85M	1.63M	3.37M	3.23M	2.81M
Short-term Borrowings	-	-	4.24M	292K	342K
Current Portion of Leases	428K	669K	776K	419K	410K
Unearned Revenue Current, Total	2.15M	616K	1.18M	2.74M	984K
Other Current Liabilities	229K	-	524K	111K	154K
Total Current Liabilities	4.72M	2.96M	10.45M	6.84M	4.88M
Long-Term Debt	3.57M	2.63M	2.72M	2.47M	2.26M
Long-Term Leases	2.13M	2.3M	2.27M	1.67M	1.63M
Unearned Revenue Non Current	572K	-	679K	888K	-
Deferred Tax Liability Non Current	14.51M	12.35M	2.16M	-	-
Other Non Current Liabilities	213K	272K	267K	224K	220K
Total Liabilities	25.71M	20.51M	18.54M	12.1M	9M
Common Stock, Total	2.12M	2.12M	2.12M	2.37M	2.6M
Additional Paid In Capital	79.29M	79.31M	79.31M	86.58M	93.82M
Retained Earnings	14.44M	10.71M	17.27M	2.79M	-31.2M
Comprehensive Income and Other	3.68M	4.18M	4.38M	5.24M	5.67M
Total Common Equity	99.53M	96.32M	103M	96.99M	70.89M
Minority Interest	236K	19K	-544K	-1.09M	-1.82M
Total Equity	99.77M	96.34M	103M	95.9M	69.08M
Total Liabilities And Equity	125M	117M	121M	108M	78.07M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	791M	791M	791M	893M	960M
ECS Total Common Shares Outstanding	791M	791M	791M	876M	960M
Book Value / Share	0.13	0.12	0.13	0.11	0.07
Tangible Book Value	99.53M	96.32M	103M	96.99M	70.89M
Tangible Book Value Per Share	0.13	0.12	0.13	0.11	0.07
Total Debt	6.12M	5.59M	10.01M	4.85M	4.64M
Net Debt	-12.44M	-5.06M	-8.45M	-3.1M	-1.47M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	236K	19K	-544K	-1.09M	-1.82M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.12M	1.03M	1.54M	1.44M	1.49M
Full Time Employees	35	48	53	39	24
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-474K	-3.73M	6.56M	-14.48M	-34M
Depreciation & Amortization - CF	778K	1.36M	1.1M	930K	772K
Depreciation & Amortization, Total	778K	1.36M	1.1M	930K	772K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	15K
(Gain) Loss on Sale of Investments - (CF)	-3.75M	11M	4.5M	2.47M	27.03M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	103K	296K	252K	558K	358K
Other Operating Activities, Total	-3.01M	-11.95M	-12.75M	-4.29M	-6.77M
Change In Accounts Receivable	-119K	167K	-3.24M	822K	5.4M
Change In Accounts Payable	318K	-250K	2.48M	-855K	928K
Change in Unearned Revenues	-	-	2.02M	-237K	-53K
Change in Other Net Operating Assets	239K	200K	-273K	153K	-32K
Cash from Operations	-5.92M	-2.92M	650K	-14.93M	-6.34M
Capital Expenditure	-241K	-481K	-574K	-112K	-78K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-4.13M	-	-	-
Investment in Marketable and Equity Securities, Total	2.46M	192K	-24K	2.15M	2M
Other Investing Activities, Total	-	-	-	12K	-
Cash from Investing	2.22M	-4.42M	-598K	2.05M	1.92M
Short Term Debt Issued, Total	-	-	4.23M	-	-
Long-Term Debt Issued, Total	235K	176K	193K	178K	144K
Total Debt Issued	235K	176K	4.43M	178K	144K
Short Term Debt Repaid, Total	-	-	-	-4.01M	-
Long-Term Debt Repaid, Total	-339K	-547K	-824K	-642K	-548K
Total Debt Repaid	-339K	-547K	-824K	-4.65M	-548K
Issuance of Common Stock	14.03M	-	-	7.47M	6.37M
Other Financing Activities, Total	-	-	-	135K	-
Cash from Financing	13.92M	-371K	3.6M	3.13M	5.97M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-
Net Change in Cash	10.23M	-7.71M	3.65M	-9.74M	1.54M
Supplemental Items
Cash Interest Paid	224K	205K	124K	42K	10K
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	178K	-10.33M	4.83M	-6.27M	-18.88M
Unlevered Free Cash Flow	376K	-10.22M	4.96M	-6.25M	-18.88M
Change In Net Working Capital	1M	3.84M	-2.2M	674K	-528K
Net Debt Issued / Repaid	-104K	-371K	3.6M	-4.47M	-404K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	0.63	-6.23	1.66	-6.07	-22
Return on Total Capital	0.76	-7.27	1.84	-6.52	-23.46
Return On Equity %	-0.75	-4.03	6.03	-15.28	-42.09
Return on Common Equity	-0.51	-3.81	6.58	-14.47	-40.5
Margin Analysis
Gross Profit Margin %	15.1	416.74	21.63	-389.26	146.82
SG&A Margin	2.79	-7.51	2.03	11.37	-1.15
EBITDA Margin %	15.46	398.03	21.65	-454.63	154.93
EBITA Margin %	12.31	424.25	19.59	-468.45	156
EBIT Margin %	12.31	424.25	19.59	-468.45	156
Income From Continuing Operations Margin %	-7.22	138.68	37.22	-638.71	165.43
Net Income Margin %	-4.92	131.06	40.71	-609.94	161.97
Net Avail. For Common Margin %	-4.92	131.06	40.71	-609.94	161.97
Normalized Net Income Margin	3.18	276.41	13.75	-273.04	97.24
Levered Free Cash Flow Margin	1.84	362.63	29.94	-264.26	89.97
Unlevered Free Cash Flow Margin	3.9	358.7	30.74	-263.21	89.97
Asset Turnover
Asset Turnover	0.08	-0.02	0.14	0.02	-0.23
Fixed Assets Turnover	4.74	-0.92	4.58	0.69	-7.2
Receivables Turnover (Average Receivables)	13.38	12.62	5.39	2.02	2.76
Short Term Liquidity
Current Ratio	4.14	4.55	2.13	1.91	1.78
Quick Ratio	4.09	4.51	2.09	1.88	1.74
Operating Cash Flow to Current Liabilities	-1.25	-0.99	0.06	-2.18	-1.3
Days Sales Outstanding (Average Receivables)	27.28	28.99	67.73	180.31	132.33
Average Days Payable Outstanding	3.33	2.35	5.75	6.27	4.29
Long Term Solvency
Total Debt/Equity	6.14	5.8	9.76	5.06	6.72
Total Debt / Total Capital	5.78	5.49	8.89	4.82	6.3
LT Debt/Equity	5.71	5.11	4.87	4.32	5.63
Long-Term Debt / Total Capital	5.38	4.83	4.44	4.11	5.28
Total Liabilities / Total Assets	20.49	17.55	15.31	11.2	11.52
EBIT / Interest Expense	3.74	-67.53	15.33	-278.02	-
EBITDA / Interest Expense	6.19	-59.95	20.68	-254.78	-
(EBITDA - Capex) / Interest Expense	5.43	-62.64	17.9	-257.58	-
Total Debt / EBITDA	3.12	-0.52	2.35	-0.48	-0.15
Net Debt / EBITDA	-6.34	0.47	-1.98	0.3	0.05
Total Debt / (EBITDA - Capex)	3.56	-0.5	2.71	-0.47	-0.14
Net Debt / (EBITDA - Capex)	-7.23	0.45	-2.29	0.3	0.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	577.69	-129.58	-665.88	-80.89	-984.08
Gross Profit, 1 Yr. Growth %